| Financial Year |
March 31 2023 |
| Monetary Funds |
248,950,291.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,068,775,257.45 |
| Advances to Suppliers |
52,584,933.86 |
| Other Receivables |
11,162,561.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
580,069,486.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,145,915.98 |
| Total Current Assets |
2,480,015,899.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
789,933,339.54 |
| Under-construction Projects |
20,411,936.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,224,442.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,583,053.61 |
| Other Non-Current Assets |
119,759,632.00 |
| Sub-Total of Non-Current Assets |
1,056,912,403.91 |
| Total Assets |
3,536,928,303.62 |
| Short-Term Loans |
853,252,010.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
464,621,500.00 |
| Accounts Payable |
192,559,754.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,670,219.00 |
| Taxes Payable |
4,193,721.99 |
| Interest Payable |
-- |
| Dividend Payable |
689,400.00 |
| Other payables |
47,088,092.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
119,571,924.79 |
| Other Current Liabilities |
591,280.08 |
| Sub-Total of Current Liabilities |
1,701,295,211.11 |
| Long-term Loans |
221,447,815.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
227,458,190.72 |
| Total Liabilities |
1,928,753,401.83 |
| Paid-In Capital(Or Share Stock) |
490,820,000.00 |
| Capital Surplus |
459,623,037.90 |
| Surplus Reserve |
77,601,184.04 |
| LESS:Treasury Stock |
19,345,680.00 |
| Undistributed Profits |
583,654,821.57 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,608,174,901.79 |
| Owner's Equity（Stockholder's Equity） |
1,608,174,901.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,536,928,303.62 |
